🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Single-patient trial aiming to provide immunological consolidation followin...
Status
Completed
Location
Ciusss-Emtl
Start Date
2024-01-16
Trial ID
NCT06391814
Treatments Being Tested
Patients have a type of a lymph node cancer called lymphoma, a tumor of the...
Status
Completed
Location
Houston Methodist Hospital
Start Date
2012-02
Trial ID
NCT01447056
Treatments Being Tested
This is a Phase II trial to evaluate the efficacy and safety of human leuko...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2011-12
Trial ID
NCT01498484
Treatments Being Tested
The primary objective of this protocol is to provide expanded access to tab...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT02822495
Treatments Being Tested
RATIONALE: Biological therapies use different ways to stimulate the immune ...
Status
Unknown
Location
Penn State Cancer Institute at Milton S. Hershey Medical Center
Start Date
2000-04
Trial ID
NCT00006100
Epstein-Barr virus (EBV) DNAemia is a common and potentially serious compli...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2025-06-01
Trial ID
NCT07368634
Treatments Being Tested
The purpose of this study is look at the safety of: * Taking a specific co...
Status
Terminated
Location
University of California, San Francisco
Start Date
2014-12-17
Trial ID
NCT02188719
Nasopharyngeal cancer (NPC) is a cancer that starts at the back of the nose...
Status
Completed
Location
Princess Margaret Hospital
Start Date
2007-12
Trial ID
NCT00706316
Treatments Being Tested
This study is a multi-center, randomized, open label, Phase III clinical tr...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2014-07
Trial ID
NCT02578641
This is an investigator-initiated, open-label, single-arm, dose-escalation ...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2025-06-01
Trial ID
NCT07450391
Treatments Being Tested